LIC
ABBV icon

Lodestar Investment Counsel’s AbbVie ABBV Stock Holding History

Lodestar Investment Counsel’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$1.58M Sell
21,724
-1,310
-6% -$103K 0.16% 77
2019
Q1 		$1.86M Sell
23,034
-2,025
-8% -$166K 0.2% 70
2018
Q4 		$2.31M Buy
25,059
+53
+0.2% +$4.66K 0.28% 63
2018
Q3 		$2.37M Sell
25,006
-216
-0.9% -$20.5K 0.26% 65
2018
Q2 		$2.34M Sell
25,222
-534
-2% -$52.2K 0.27% 63
2018
Q1 		$2.44M Buy
25,756
+575
+2% +$63.2K 0.28% 62
2017
Q4 		$2.44M Sell
25,181
-100
-0.4% -$9.43K 0.28% 63
2017
Q3 		$2.25M Buy
25,281
+1,550
+7% +$118K 0.28% 62
2017
Q2 		$1.72M Buy
23,731
+150
+0.6% +$10.1K 0.22% 64
2017
Q1 		$1.54M Sell
23,581
-1,696
-7% -$107K 0.2% 65
2016
Q4 		$1.58M Buy
25,277
+640
+3% +$39.1K 0.21% 65
2016
Q3 		$1.55M Sell
24,637
-300
-1% -$19.4K 0.21% 63
2016
Q2 		$1.54M Buy
24,937
+875
+4% +$53.3K 0.22% 63
2016
Q1 		$1.37M Buy
24,062
+9,763
+68% +$544K 0.2% 65
2015
Q4 		$847K Hold
14,299
– – 0.13% 77
2015
Q3 		$778K Sell
14,299
-100
-0.7% -$6.51K 0.13% 80
2015
Q2 		$967K Sell
14,399
-50
-0.3% -$3.26K 0.15% 72
2015
Q1 		$846K Sell
14,449
-288
-2% -$17.4K 0.13% 80
2014
Q4 		$964K Hold
14,737
– – 0.28% 51
2014
Q3 		$851K Sell
14,737
-2,405
-14% -$134K 0.26% 53
2014
Q2 		$967K Hold
17,142
– – 0.29% 51
2014
Q1 		$881K Sell
17,142
-2,354
-12% -$119K 0.28% 55
2013
Q4 		$1.03M Sell
19,496
-425
-2% -$20.9K 0.33% 51
2013
Q3 		$891K Hold
19,921
– – 0.32% 53
2013
Q2 		$824K Buy
+19,921
New +$871K 0.32% 52

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Lodestar Investment Counsel's ABBV Position: Q2 2019 in Review

Lodestar Investment Counsel reduced its AbbVie (ABBV) stake by 5.7% in Q2 2019, selling an estimated $103K and leaving 21,724 shares worth $1.58M. The position accounts for 0.16% of the portfolio, ranked #77.

Lodestar Investment Counsel first reported a position in ABBV in Q2 2013 and has held it in 25 quarters since. The position peaked at $2.44M in Q1 2018. 2,021 funds tracked by Wall St. Rank hold ABBV as of Q2 2019.

  • Lodestar Investment Counsel held 21,724 shares of AbbVie worth $1.58M as of Q2 2019.
  • Lodestar Investment Counsel sold 1,310 AbbVie shares in Q2 2019, an estimated $103K.
  • AbbVie made up 0.16% of Lodestar Investment Counsel's portfolio in Q2 2019, its #77 holding.
  • Lodestar Investment Counsel first reported a position in AbbVie in Q2 2013 and has held it in 25 quarters since.
  • Lodestar Investment Counsel's AbbVie position peaked at $2.44M in Q1 2018.
  • 2,021 funds tracked by Wall St. Rank held AbbVie as of Q2 2019.

Based on Lodestar Investment Counsel's 13F filing for Q2 2019, filed 10 Jul 2019.